By B. Mazin. Tennessee Wesleyan College. 2019.
Finally generic januvia 100 mg visa, eradication of normal thyroid tissue will permit uptake of therapeutic radioiodine by malignant tissue generic 100mg januvia overnight delivery, maximizing the therapeutic benefit purchase 100mg januvia. Physiological basis Radioiodine, in a manner identical to iodine, is concentrated in functioning thyroid tissue, either normal thyroid tissue or thyroid carcinoma. Most differentiated thyroid cancers concentrate iodine to a variable extent; papillary and follicular cancers invariably concentrate iodine, while many Hürthle cell and other ‘tall cell’ variants of differentiated thyroid cancer may not concentrate iodine. Indications The indications are iodine-avid thyroid remnants or metastatic disease in patients with thyroid carcinoma, usually papillary or follicular. Equipment Iodine-131 therapy is sometimes carried out, especially in patients suspected to have metastatic cancer, after demonstration of iodine-avid thyroid tissue (normal or malignant) by a gamma camera or whole body counter. Most centres carry out gamma camera imaging using a high energy, general purpose collimator. Most centres also carry out imaging with comparable imaging methods, to demonstrate targeting of therapeutic 131I to thyroid tissue. No special equipment is required for outpatient therapy, apart from adequate shielding of the 131I and appropriate monitoring of patients to ensure adherence to radiation safety criteria for outpatient therapy. Radiopharmaceuticals Iodine-131, in the form of sodium iodide, is administered orally. Action prior to 131I therapy 131 Patients at intermediate or high risk of thyroid cancer usually receive I therapy after definitive thyroid surgery (usually total or radical thyroidectomy, with recurrent laryngeal nerve and parathyroid preservation). Skin sterilization for thyroid surgery must not use an iodine containing compound. Patients must not receive thyroid hormone replacement for at least four weeks prior to 131I therapy. Patients who tolerate hormone withdrawal poorly may receive tri-iodothyronine (T3) until two weeks prior to therapy. No intravenous contrast should be administered for at least two months prior to planned evaluation and therapy. Patients should be encouraged to reduce the iodine content in their diet to optimize uptake of 131I by thyroid tissue. Serum thyroglobulin estimations are usually carried out immediately 131 prior to administration of I tracer. A tracer study may be carried out prior to administration of 131I therapy, to ensure 131I uptake in thyroid tissue and/or in metastatically diseased tissue. Whole body imaging at 72 hours should also be carried out, especially when the results of neck imaging are negative. A form signed by the patient giving their informed consent for therapy is required. Therapy Ablative therapy is defined as that given immediately following definitive surgery. When the mass of thyroid remnant can be estimated, for example 131 using ultrasound, a dose of I calculated to deliver 30–50 Gy to the thyroid remnant may also be used. Ablative therapy should be given to all patients with iodine-avid thyroid/malignant tissue in the neck or elsewhere, or in those patients who, immediately after surgery, have no evidence of iodine-avid thyroid tissue 72 hours after oral administration of 131I tracer but who have elevated serum thyroglobulin levels. This evaluation is carried out not less than four weeks after cessation of thyroid hormone replacement or, if the patient cannot tolerate hormone withdrawal, by the following regimen: —Stop levothyroxine and substitute with a comparable dose of T3 for two weeks. Anterior and posterior whole body imaging should be carried out at least 72 hours after administration of the tracer, using high energy collimation. An alternative to whole body imaging is static anterior and posterior imaging of the relevant areas (head, neck, chest, abdomen, pelvis and lower extremities), taken for at least 10 min each. If there is evidence of iodine-avid disease from scintigraphy and/or if the serum thyroglobulin level is elevated, the patient should be treated with 131I. The maximum safe dose of 131I has been found to be that which delivers no more than 2 Gy to the blood. Post-therapy follow-up Hormone replacement may be resumed two days after treatment. In most centres, anterior and posterior images of the body are obtained a week to 10 days after 131I therapy to ensure targeting. This can be done most reliably when the patient is no longer on T4 or T3 treatment. When patients are treated at the maximum safe dose, haemato- logical evaluation should be carried out between four and six weeks after therapy, to ensure lack of haematopoietic toxicity. Patients are usually not re-treated earlier than six months after therapy, unless there is evidence of rapidly progressive disease as evidenced by a progressive rise in serum thyroglobulin and/or radiographic evidence of progressive disease. Two successive negative whole body studies, with concurrent non-measurable serum thyroglobulin levels, separated by intervals of at least six months, indicate successful therapy. The patient may then be managed by serum thyroglobulin estimations twice yearly for five years and then annually for at least another five years. Suggestions for a written instruction sheet for patients Why are you going to receive radioactive treatment? You are going to receive radioactive iodine treatment because your doctors have decided that this is the best option for your disease. This radiation damages the tissue, producing the desired beneficial effect for your 458 6. However, small quantities of the radiation present in your body may reach people close to you, exposing them to this radiation unnecessarily. Although there is no evidence that this radiation exposure has damaged other individuals, you should avoid exposing others to any unnecessary radiation. Radioactive iodine is given in a capsule or liquid form by mouth in variable quantities according to the type of your disease. Your treating doctor and the physician who will actually administer the treatment determine the dose. According to the administered dose and your condition, it is possible that you may be hospitalized for some days. Women must be absolutely sure that they are not pregnant at the time they receive the treatment and should not be breast feeding. Food should not be ingested in the two hours before treatment and, in some cases, a low iodine diet will be recommended for a few days. Most of the iodine not retained in thyroid tissue is eliminated through the urine within 48 hours. This means that the possibility of unnecessary radiation exposure to other people also decreases in a matter of days. Radiation emitted by the radioactive iodine in your body is very similar to the X rays used in radiological examinations. For this reason, people who remain close to you for prolonged times may be exposed to unnecessary and avoidable radiation. Besides the above mentioned radiation, there is the possibility that other people close to you may directly ingest small quantities of radioactive iodine eliminated by your body in the saliva or sweat. The three principles to avoid unnecessary radiation exposure are: (1) Distance: Do not get too close to any other person.
In this example purchase januvia pills in toronto, patients who do not respond ( ) are followed by a patient treated at the next higher dose size; vice versa trusted januvia 100mg, patients who do respond ( ) are followed by a patient treated at the next lower dose discount januvia. Patients or groups requires an independent coordinator who allocates of patients are paired, and then treated with alter- each patient, as he/she is recruited, to one or other native therapies. The independent coordinator al- records the result of each comparison with time, locates each patient so as to minimize the difference and crossing a boundary on the chart, after an between the two treatment groups, according to unpredictable number of paired comparisons, prospectively defined patient characteristics, e. For a trial of a new therapy age, sex, genotype, disease state or stage, or con- that can both benefit and harm the patient, a typical comitant therapy. The design of control charts is always to a treatment group by the chance of a random- prospective, and their shape depends upon the a ization schedule. Second, the independent co- under test, control charts can be rhomboidal, par- ordinator need only allocate patients to anonym- allelogram-shaped, or many other shapes. White- ous groups A or B, and the study pharmacist need head (1999) is the best entry to the literature on this be the only person who knows which treatments specialized topic. If the patient receiving treatment A does better than the one receiving treatment B (A > B), then the line moves upwards; vice versa, if the patient receiving B does better than the one receiving A (B > A), then the line moves downward. This is of use when, for example, it may be desirable to expose Stratification Studies fewer patients to placebo than to active therapy, especially when conducting a trial of compounds In pivotal studies, large numbers of patients are whose properties are fairly well known or may be studied so that their diverse clinical characteristics predicted with some confidence. On the other hand, when designing a mini- then randomized to active or placebo for a total of mization study, the assumption is that the treat- four treatment groups, although only two test ment groups will be devoid of relevant differences treatments. Separate statistical analyses for the in baseline characteristics, and therefore clinical strata can then be planned, and the study size significance might only be assumed to follow from adjusted accordingly. Regulatory authorities it increases, may compensate for the reduction in will often approve indications with caveats based variability amongst study group samples, and thus on such subsets. The risk of stratification studies is where, in any case, large numbers of patients are that conservative regulatory authorities will needed for a tolerability database. If the controlled want to see statistical significance in all patient clinical trial is a gold standard, then it would be subsets before allowing a short, broad indication wrong to assert that the independent treatment al- in labeling. Trials of can then be ethical to recruit patients into a study cardiovascular drugs, on an almost epidemi- with inclusion criteria that include that they are ological scale, have been the most significant already being treated with the drug of interest. Literally Almost any of the designs discussed above may tens of thousands of patients have been recruited then be used, where patients are randomized either under these protocols with case report forms to remain on the treatment of interest or to be having fewer than 10 pages for each patient. These two-stage designs usually include a Kaplan±Meier analysis and other epidemiological small number of open label-treated patients (usu- approaches may also be applied to such data- ally n 14) in the first stage. Stopping a clinical trial because of an emergent Large simple studies can thus create undue confi- safety problem, either by a medical monitor or by dence in product tolerability (`thousands of pa- a safety committee, is always a unique situation. There are several statistical points of view on this subject, and Efficacy Issues regulatory authorities have a habit of believing only the most conservative. Efficacy, like safety, of thumb, pharmaceutical physicians should expect can cause ethical concerns to the pharmaceutical statisticians to provide alternatives that obey a physician when he/she suspects that patients will be simple subtraction rule. In that Interim Efficacy Analyses case, if the study continues after the interim analy- sis fails to achieve p < 0:01, then it will be required These usually make a mess! They require either that to achieve approximately p < 0:04 for the whole the overall size of the trial has to be greater than if patient population in the final statistical analysis no interim analysis was performed, or that a in order to demonstrate the efficacy of the test smaller a must be accepted as indicating statistical drug. Stopping method which takes into account the uncertainties the trial by reason of the unethical basis for treating associated with small and unequal treatment group the patients with anything else is a rare and pleas- sizes. Eventu- that, when considering a new trial, he/she should ally, the several test therapies are reduced to two at least consider whether a Bayesian approach and a definitive demonstration of superiority or might help. It is unlikely imum number of patients have entered the trial, an that enough patients could ever be collected at any interim analysis is done every time another patient reasonably small number of study sites for any completes the trial. In these that although the number of patients required to cases, probably the best that can be accomplished complete a sequential design study are undefined at is to collect and retrospectively analyze as many the beginning, the treatment allocations are none- such cases as possible. Thus, the sequential designs are still, retrospective risk ratios for benefit and harm can essentially, a frequentist methodology, and not be calculated. One example is the thus are, probably unduly, little utilized by gener- effectiveness of dantrolene in malignant hyperther- alist pharmaceutical physicians. Special populations may require small-scale from several to one or two; patients recruited after studies to supplement a traditional two-study, this transition may be regarded as patients in a large-scale registration development scheme. Fur- statistician and, it may be added, a statistician who thermore, even for conventional indications, the is not, him/herself, philosophically opposed to resource implications of pivotal studies are usually Bayesian rather than frequentist thinking. The de- much greater than any earlier phase of develop- cision to employ a Bayesian design for a clinical ment, and efficient resource utilization becomes trial will be viewed as courageous in most com- exponentially more important than before. The panies, and there will be many clinical trials for incorporation of pharmacoeconomic and human- which an orthodox, frequentist approach will be istic outcomes alongside the primary registration selected, for several good reasons. However, these data are also needed for needed to harm (and corresponding reciprocals) derivative documents within the application, one can be used to compare drugs for this purpose. In practice, the clinician who must decide whether to prescribe, clinicians make prescribing decisions based upon: or the clinical trialist who must decide whether to (a) a subset of the published information that commit patients to a particular study design, both might be available about the drug (labeling, drug being prospective decisions. Often, unlike for ap- if it is to recede, is only partly due to the action of proved drugs, there is much less information to the drug, because the extreme variability intro- go on. This is obligatory: if the patients to make their own benefit±risk assess- answers to the clinical trial questions were known, ments, albeit with some guidance (Marsh 1990). In general, the trials cation links between the two research teams must are larger (often having up to several thousand be established early in the clinical program, to patients), the inclusion/exclusion conditions are provide information necessary to the conduct of less restrictive, and the end-points may be less ob- later trials and to advise the marketing department jective (e. Modifying the prod- ness, patient satisfaction, quality of life, or another uct requires the development of a pharmaceutical parameter that may be helpful in increasing market process and evidence of bioequivalence. The aim is to publish the trial (preferably in a be particularly difficult for a product with a unique peer-reviewed journal) and use the data in a pro- dosage form (e. A study syn- must have well-defined end-points that are relevant opsis is usually required by the competing sponsor, for both products and include a range of doses so that the design and hypotheses can be evaluated for each product to ensure an optimal response. The synopsis also alerts the Double-blind and, if necessary, double-dummy competing sponsor to the ultimate aims of the studies are generally favored over open-label trials. In the earlier phases of drug development, open-label trials are rarely appropriate, except for Sometimes, it is not possible to demonstrate super- very early safety and efficacy (e. Open-label studies are often useful in the and safety equivalence, particularly if the later phases of drug development and when con- marketing strategy is based on price. In addition, equivalence trials re- such as the famous Framingham study, but can quire the trialist to choose a clinically relevant treat- also be used in drug studies where the effects of mentdifference todeterminetheappropriatesample treatment on various variables (e. Since subjects are enrolled in a non- randomized manner, some of the ethical issues in- Megatrials herent in randomized trials, in which subjects have no choice as to which treatment group they are Megatrials are commonly used to establish small allocated, can be avoided. The cohort being followed may not be repre- they can be important marketing tools and can sentative of the larger population for whom the justify the use of the new and usually more expen- drug is intended. Megatrials appear to have had their biggest impact when used to compare different allo- Further problems are that open-label studies may cated protocols with respect to a selected outcome. To assist independent investigators with this process, many large pharma- Once a product is released onto the market, the ceutical companies have set up investigator grant number of patients exposed to it increases signifi- programs.
Economics: What is a cost effective strategy in one country and at a particular point in time may not translate to a cost effective strategy in another country or at a different a point in time buy discount januvia on line. Homelessness is a major problem among former inmates of psychiatric hospitals discount 100 mg januvia free shipping, be they patients who stayed for long periods of time in hospital or who are frequently in and out of hospital order januvia with visa. Rents for private accommodation has tended to spiral beyond the reach of those discharged from hospital. Walsh ea (1998) defined absconders as single, involuntary, schizophrenic or personality disordered. Factors predictive of this phenomenon are summarised in the table (Mitchell & Selmes, 2007). Relief admission refers to admission to relief carers during a crisis, whereas respite admission refers to regular, pre-planned breaks from caring. The (Irish) Mental Health Act 2001 provides for patients/consumers sitting on the Mental Health Act Commission. However, comparison with control groups failed to support the conclusion that these results are due to constraints on 3268 outpatients. The English Mental Health (Patients in the Community) Act 1995 allowed the right to remove a patient to a place of treatment wherein the patient could not be given treatment unless he/she so wished! If treatment is to be given forcibly the patient must receive such treatment in hospital. Recall must be in writing and handed directly to the patient, put through their letter box or posted (first class) to their last known address. Whilst stranger homicides increased in England and Wales between 1967 and 1997, this was not attributable to homicides by mentally ill people. Although there are infamous exceptions, stranger homicides are more likely to be related to alcohol and drug abuse by young males. Supervision orders have been described (Holloway, 1994) as a bureaucratic solution to inadequate resources and (McCreadie, 2000) as a rod with which to beat psychiatrists should things go wrong. The names of particular patients requiring supervision (violent, suicidal, or self-neglecting) are placed on a special register and close follow up is mandated. Inclusion criteria tend to be vague and such registers present litigation dilemmas for workers – who to include, who to exclude? Despite exhortations, there is little evidence that supervision registers are effective in practice. Prisons: Concern has been raised over the number of psychiatrically ill and intellectually disabled people in prison. For example, 2% of male and female English prisoners were reported to be psychotic. If a patient with capacity refuses to allow staff to inform relatives of the occurrence of seclusion this must be honoured (and documented) unless there are overriding legal or professional considerations. If a patient is subject to 7 or more seclusion orders over 7 consecutive days the Inspector of Mental Health Services must be told of this in writing with reasons given for the practice and details of alternative therapeutic options that were considered. Each approved centre’s policy must state what attempts are to be made to minimise use of seclusion. In this author’s view, there is still a need for gentle restraint 3271 (‘soft supports’, Posey restraints ) in confused, demented elderly patients who might otherwise need extra medication or suffer fall or other injuries. Common sense, knowledge of local laws and protocols, supervision by senior personnel and inspectorates, and a humanitarian outlook should avoid abuses. Their use should be strictly supervised and documented and subject to regular review. A flat hand should fit between the device and the patient to ensure that it does not interfere with breathing. Injuries may result from hitting the head of the sides, climbing over the sides, unlatching the device, or catching the head or neck between the bars. Gaps should not occur between the mattress and the cot side (entrapment hazard), and the mattress (e. A risk-benefit assessment 3272 should be performed before use and periodically thereafter. Disaster and military psychiatry A disaster is severe ecological/psychosocial disruption that overwhelms the coping powers of a population. In war zones, debriefing was employed in order to return soldiers to frontline service. Health worries that fail to reach syndromal level are common following combat and other catastrophic events. People exposed to warfare or catastrophes may develop psychiatric problems for many reasons: prior coping and functional capacities, previous exposure, sex (e. The soldier who is subjected to combat-related psychic trauma is helped if he feels safe and properly cared for after removal from the frontline and if he knows that the folks back home care about him. Society can help to minimise traumatisation by recognising the sacrifices of its soldiers and by not confusing their 3275 political beliefs and the efforts of its combatants. Recent large scale catastrophes have included famines, bombings, school campus mass shootings, civil wars, aviation and other-travel related events, flooding, and earthquakes. Disasters Natural – hurricanes, conflagrations, flooding, high winds, icebergs, heat waves, etc Manmade – (a) accidental (e. Medico-surgical preparation for such events must include psychiatrists because of (a) the psychological effects of disaster and (b) the experiences of psychiatrists in dealing with strong emotions in victims and tolerating strong personal affect. Psychiatrists should have input into organising appropriate responses to catastrophe. They should employ a wide range of interventions - psychotherapeutic, pharmacological, and group work. Interventions will encompass immediate and longer term involvement of mental health professionals. Friends and relations, witnesses, helpers (including professionals), and direct victims may be traumatised. The fire, which killed 492 people, seems to have been caused by a flammable methyl chloride leak from a faulty refrigerator. The best known victim was Charles ‘Buck’ Jones (1891-1942: born Charles Gebhart) a cowboy film star. In such chaotic 3276 situations it should be recalled that most people cope with supportive measures (listening, advice, information, normalising experiences, etc) and that what differentiates the normal from the abnormal is the level of incapacity caused as well as the degree of interference with functioning, relating, and employment of coping powers. Services offered should be culture-friendly and the practitioner should not ignore traditional approaches to diversity, e. Medical services may be over-stretched during warfare or other calamities and trained non-medical personnel may need to be called on. Conclusions 3277 Community-based services, just like intramural services, vary enormously in quality and resources. Even politicians have occasionally expressed fears that ‘the pendulum has swung too far’ on occasion. Under the Irish Housing (Miscellaneous Provisions) Act 2002 local authorities must provide housing to people in their area who require it. The best asylums provided a wide range of services for the chronic mental patient that are difficult to reproduce extramurally. People who know little about psychiatry make the decisions and ‘generic mental health workers’ are tasked with work that they are not qualified to undertake.
We had a number of poor interventions in his case and I suppose that it was at that time that I 5 began to query conventional medicine buy 100 mg januvia with visa. This experience again gave me an insight into the limitations of the orthodox medical profession januvia 100 mg low price. I now know that these were deficiency illnesses order discount januvia on line, he had eczema, bad dyslexia and hyperactivity. We did finally start a gluten free diet and Roger McDougal advised vitamin and mineral supplements. The need for nutritional advice for coeliac disease was evident, but just as Dr Jean Monro had found, Belinda Barnes began to suffer the irrational hostility of some orthodox doctors. She was corresponding with people, meeting experts privately and at conferences, and she was reading voraciously. Looking back, she points out that organisations like Foresight do not just suddenly appear, ready made. They have a long and rickety gestation, particularly when powerful interests like the orthodox medical profession resist them. In 1990, twelve years after starting Foresight, Belinda Barnes wrote Planning for a healthy 5 baby: essential reading for all future parents, with Suzanne Gail Bradley. This book managed to do something which the whole of orthodox medicine had been unable to do, about a subject as simple and as popular as pregnancy and pre-conceptual care. The book maps out the steps that possible parents may take prior to conception to ensure the optimum health of their child. In the introduction to the book Belinda Barnes explains how a friendly and inquisitive letter to an American doctor, whose paper she had read in the Journal of Orthomolecular Psychiatry, set her off on the serious quest for knowledge about nutrition. When Elizabeth Lodge-Rees next came to stay, she and Belinda Barnes tried to organise meetings with orthodox doctors and hold a press conference about nutrition. By that time, medical science and its industrial backers were moving into pharmacology and genetics. Mrs Barnes was, however, beginning to meet the people who would form the supportive structure of Foresight — the doctors and scientific analysts on whom Foresight would depend to formulate programmes. She was in touch with the Schizophrenia Association of Great Britain and on the committee of Sanity, the organisation to which Dr Jean Monro was a Medical Adviser. By the late seventies she became convinced that the majority of early child health problems were the consequence of vitamin and mineral deficiencies or a high intake of toxic metals and pesticides. She met Professor Derek Bryce Smith who was working on the damaging effects of lead in petrol. As her commitment grew, Mrs Barnes began to notice that certain areas of her work were, for one reason or another, being suppressed. In America, Elizabeth Lodge-Rees, who was using hair analysis and working on vitamin and mineral deficiencies, was also having a hard time. Belinda Barnes found that so much of the original work in the field of nutrition, like that done by Pfeiffer on zinc, was quickly relegated to a sub-culture of alternative health practice. Barnes saw also that Dr Jean Monro, with whom she was now working, found it very difficult to get her work published in journals. Dr Ellen Grant, who was doing extensive scientific work on the deleterious effects of 16 the birth control pill, was being shunted to the margins of science and medicine. Belinda Barnes, despite being an amateur, has, however, a more rigorous and intellectual attitude than many orthodox professionals. The history of nutritional medicine is real history, the history of a real movement which has gained knowledge since the 1930s. It is a scientifically serious movement, one which is documented in scientific and medical research papers. Patients are referred from a wide variety of sources, some from midwives and health visitors because they have had miscarriages, while increasingly others come via their general practitioner. The problems that the pregnant mother and the pre-conceptual parents face in the nineties are perhaps more serious and yet more submerged than those faced in previous decades. Because of pesticide residues in food, there are now many more allergic conditions amongst children and children are getting them even sooner. We now know for instance that pesticides reduce the bio-availability of magnesium. The number of children born with complaints like eczema, epilepsy and asthma is increasing all the time, seemingly in relation to the increased use of chemicals in the environment. In relation to chemical solutions to these problems, there is a kind of circular pattern. A chemical company may make a crop spray which gives people allergic, cold-type symptoms, and the same company will market an over-the-counter remedy for such illness. It listed all chemical food additives and colour coded them, so that they could be easily identified as those which might be dangerous (red), those about which there were conflicting views (orange) and finally those which appeared to have no adverse side effects (green). Also in 1986, well into its critique of pesticides and chemical additives in food, Foresight 18 produced its own wholefood cookery book and Belinda Barnes wrote The Hyperactive 19 Child, a book which has become a classic. The cynicism of many orthodox doctors and a lack of patient participation made it more or less inevitable that Foresight would be pushed to the margins. However valuable its work, Foresight is part of an underclass of health organisations. Access to media is restricted, and there are few windows in the prevalent medical ideology through which it can voice its opinions. By the early eighties, Foresight and Belinda Barnes had met up with the large number of individuals and organisations that have been forced by the orthodox monopoly to inhabit that same extensive underclass of health theorists and clinicians. Professor John Dickerson, Professor of Human Nutrition at the University of Surrey and Dr Neil Ward, a leading figure in metal-to-metal interaction in the body, were both advising Foresight about toxic metals and nutrition. Dr Jean Monro was acting as a medical adviser to Foresight, and Belinda Barnes was attending the seminars which Dr Monro regularly organised at the Breakspear Hospital. By 1985, Mrs Barnes and Foresight had placed themselves in the very centre of the growing lobby on nutrition. Foresight had originally sent hair to America for hair mineral analysis, but in 1985 Dr Stephen Davies and Biolab began doing their analysis in London. By this time, thirty or forty nutritional doctors were working with would-be parents on a wide range of problems. Belinda Barnes was still a long way from her ultimate goal of getting pre-conceptual care integrated into the National Health Service, but at least Foresight had a regular following and appeared to have been accepted by many professionals in the field. I was fearful of their methods and wondered if in the future I would be the subject of an 1 attack It was not until the late sixties that a number of large companies began to compete in the vitamin and supplement market. Until this time the development of the health food and natural therapy market from the nineteen thirties can be seen mainly as the growth of a scattered number of small, often family businesses based upon the personal and sometimes idiosyncratic experience of their founders. Whether they manufactured or sold mineral waters, herbal remedies, health foods or chemical tablets, these businesses were inevitably small because their customers were on the philosophical and cultural margins. The advent of a youth movement in the late sixties which grew out of a generation not pressed by economic necessity directly from school to factory, radically changed views about personal health and well-being. Many of those who participated in this emancipation found themselves collectively part of what came to be called the Age of Aquarius, a New Age of consciousness, an apparently softer age which eschewed war, authoritarianism and forced industrial work, replacing them with communal living, the deification of nature and the exploration of an inner spiritual life. It was on this tide of the New Age, as it broke into the seventies, that ideas about health foods, organic fanning and vitamins became meaningful for a large number of people for the first time since the nineteen thirties. During this period, many of the idiosyncratic small family businesses began to experience a renaissance along with a burgeoning number of health food shops and therapists.
9 of 10 - Review by B. Mazin
Votes: 171 votes
Total customer reviews: 171